BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338 AND Prognosis
5 results:

  • 1. VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
    Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
    EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RNA-binding protein p54
    Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
    Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The nitric oxide pathway: is L-arginine a gate to the new millennium medicine? A meta-analysis of L-arginine effects.
    Fisman EZ; Tenenbaum A; Shapira I; Pines A; Motro M
    J Med; 1999; 30(3-4):131-48. PubMed ID: 17312667
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Elective radiotherapy in breast carcinoma].
    Nervi C; Arcangeli G; Tirindelli Danesi D; Creton G
    Tumori; 1982 Feb; 68(1):73-80. PubMed ID: 7071949
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.